MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

CBUS — Cibus, Inc. Class A Common Stock

Nasdaq

Cibus, Inc. Class A Common Stock

CompareBack to Screener
$1.71
+0.08(+4.91%)
O
1.63
H
1.76
L
1.63
V
247.44K
⏱️ End-of-day dataAs of Oct 2, 2026

Chart

About CBUS

Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.

IndustryAGRICULTURAL CHEMICALS
SectorNot available
IPO DateJul 20, 2017
Employees118
Stock ExchangeNasdaq
Ticker SymbolCBUS

Key Financial Statistics

Market Cap$116.17M
P/E RatioN/A
Dividend YieldNone
EPSN/A
BetaN/A
52-Week Range$1.09 - $4.19
52-Week Avg Volume391.7K
VWAP$1.70
Transactions2,004
Total Recorded Bars2,314 days